Skip to main content
SpringerLink
Log in

Susac’s syndrome as an autoimmune complication of alemtuzumab-associated immune reconstitution

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. García-Carrasco M, Mendoza-Pinto C, Cervera R (2014) Diagnosis and classification of Susac syndrome. Autoimmun Rev 13(4–5):347–350. https://doi.org/10.1016/j.autrev.2014.01.038

    Article  PubMed  Google Scholar 

  2. Laughlin S (2001) Energy as a constraint on the coding and processing of sensory information. Curr Opin Neurobiol 11(4):475–480. https://doi.org/10.1016/S0959-4388(00)00237-3

    Article  CAS  PubMed  Google Scholar 

  3. Kleffner I et al (2016) Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry 87(12):1287–1295. https://doi.org/10.1136/jnnp-2016-314295

    Article  PubMed  Google Scholar 

  4. Grygiel-Górniak B, Puszczewicz M, Czaplicka E (2015) Susac syndrome–clinical insight and strategies of therapy. Eur Rev Med Pharmacol Sci 19(9):1729–1735

    PubMed  Google Scholar 

  5. Zengin Karahan S et al (2019) Susac Syndrome: clinical characteristics, diagnostic findings and treatment in 19 cases. Mult Scler Relat Disord 33:94–99. https://doi.org/10.1016/j.msard.2019.05.018

    Article  CAS  PubMed  Google Scholar 

  6. Kleffner I et al (2010) Neuroimaging in Susac’s syndrome: focus on DTI. J Neurol Sci 299(1):92–96. https://doi.org/10.1016/j.jns.2010.08.028

    Article  CAS  PubMed  Google Scholar 

  7. Magro CM, Poe JC, Lubow M, Susac JO (2011) An organ-specific autoimmune endotheliopathy syndrome associated with anti-endothelial cell antibodies. Am J Clin Pathol 136(6):903. https://doi.org/10.1309/AJCPERI7LC4VNFYK

    Article  CAS  PubMed  Google Scholar 

  8. Egan RA (2019) Diagnostic criteria and treatment algorithm for Susac syndrome. J Neuroophthalmol 39(1):60–67. https://doi.org/10.1097/WNO.0000000000000677

    Article  PubMed  Google Scholar 

  9. Coles AJ et al (1999) Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet 354(9191):1691–1695. https://doi.org/10.1016/S0140-6736(99)02429-0

    Article  CAS  PubMed  Google Scholar 

  10. Jones JL et al (2013) Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation. PNAS. https://doi.org/10.1073/pnas.1313654110

    Article  PubMed  PubMed Central  Google Scholar 

  11. Willis MD, Robertson NP (2016) Alemtuzumab for multiple sclerosis. Curr Neurol Neurosci Rep. https://doi.org/10.1007/s11910-016-0685-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Clinical Medicine, Cambridge University Hospitals, Cambridge, UK

    Amir Ahmed & Zi Qi Kok

  2. Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

    Alasdair Coles & Sarah J. Crisp

  3. Department of Radiology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK

    Daniel J. Scoffings

Authors
  1. Amir Ahmed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zi Qi Kok
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alasdair Coles
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel J. Scoffings
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Sarah J. Crisp
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

AC, DJS and SJC managed the patient and reviewed the manuscript; ZQK and AA wrote the manuscript.

Corresponding author

Correspondence to Sarah J. Crisp.

Ethics declarations

Conflicts of interest

The authors declare that there are no competing interests associated with the manuscript.

Ethical approval

The authors declare that the study has been conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

Informed consent

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmed, A., Kok, Z.Q., Coles, A. et al. Susac’s syndrome as an autoimmune complication of alemtuzumab-associated immune reconstitution. J Neurol 269, 1695–1697 (2022). https://doi.org/10.1007/s00415-021-10802-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-021-10802-4

Search

Navigation